当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Stereotactic Body actinotherapy for the Definitive Treatment of Early Stage excretory organ Cancer: A Survival Comparison with Surgery

Henry Austen

Partial excision is that the most well-liked definitive treatment for early stage excretory organ cancer, with neoplasm ablative techniques or active police investigation reserved for patients not undergoing surgery. Stereotactic body irradiation (SBRT) has emerged as a possible noninvasive various for patients with early stage excretory organ cancer not amenable to surgery, with early reports suggesting glorious rates of native management and restricted toxicity.The national cancer information from 2004 to 2014 was queried for patients UN agency received an identification of excretory organ cancer. Treatments were categorised as surgery (partial or total nephrectomy), neoplasm ablation (cryoablation or thermal ablation), SBRT (radiation medical care in five fractions or less to a complete biological effective dose [BED10] of seventy two or more), or observation. A propensity score was generated by multinomial logistical regression. A Cox proportional hazards model was suited verify association between overall survival and treatment cluster with propensity score changes for patient, demographic, and treatment characteristics.